Status
Conditions
Treatments
About
The GPS Registry is a multi-centre, single-arm, non-interventional (observational) registry. In addition to collecting data from patients treated as per standard clinical practice, the Registry will also regularly collect telemetric Home Blood Pressure (HBP) measurements and Patient Reported Outcome (PRO) data via a standardized quality of life questionnaire. The objective of the GPS Registry is to document the long-term safety and effectiveness of the commercially available Paradise Ultrasound Renal Denervation System when used per its labelling in patients deemed to be candidates for RDN as per physician's assessment.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Patients who meet any of the contraindications listed in the Instructions for Use will be excluded.
The contraindications are:
3,000 participants in 1 patient group
Loading...
Central trial contact
Helen Reeve-Stoffer, PhD; Lea Doyle
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal